A detailed history of Black Rock Inc. transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,474,477 shares of STTK stock, worth $9.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,474,477
Previous 529,513 367.31%
Holding current value
$9.43 Million
Previous $4.73 Million 101.8%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$3.56 - $11.18 $6.92 Million - $21.7 Million
1,944,964 Added 367.31%
2,474,477 $9.55 Million
Q1 2024

May 10, 2024

BUY
$7.37 - $10.09 $285,115 - $390,341
38,686 Added 7.88%
529,513 $4.73 Million
Q4 2023

Feb 13, 2024

SELL
$1.37 - $7.24 $4,514 - $23,855
-3,295 Reduced 0.67%
490,827 $3.5 Million
Q3 2023

Nov 13, 2023

SELL
$1.42 - $3.16 $34,836 - $77,524
-24,533 Reduced 4.73%
494,122 $751,000
Q2 2023

Aug 11, 2023

BUY
$2.52 - $3.66 $35,242 - $51,185
13,985 Added 2.77%
518,655 $1.62 Million
Q1 2023

May 12, 2023

BUY
$2.5 - $4.72 $2,632 - $4,970
1,053 Added 0.21%
504,670 $1.48 Million
Q4 2022

Feb 13, 2023

SELL
$1.96 - $3.26 $491,203 - $817,001
-250,614 Reduced 33.23%
503,617 $1.16 Million
Q3 2022

Nov 14, 2022

SELL
$2.6 - $5.52 $73,603 - $156,265
-28,309 Reduced 3.62%
754,231 $2.04 Million
Q2 2022

Aug 12, 2022

SELL
$2.7 - $4.59 $3.78 Million - $6.42 Million
-1,399,247 Reduced 64.13%
782,540 $3.18 Million
Q1 2022

May 12, 2022

SELL
$4.22 - $8.89 $118,295 - $249,204
-28,032 Reduced 1.27%
2,181,787 $9.3 Million
Q4 2021

Feb 10, 2022

BUY
$8.36 - $21.08 $3.26 Million - $8.22 Million
390,036 Added 21.43%
2,209,819 $18.8 Million
Q3 2021

Nov 09, 2021

BUY
$17.57 - $28.95 $1.38 Million - $2.27 Million
78,441 Added 4.5%
1,819,783 $37.1 Million
Q2 2021

Aug 11, 2021

BUY
$24.14 - $37.68 $42 Million - $65.6 Million
1,741,342 New
1,741,342 $50.5 Million

Others Institutions Holding STTK

About Shattuck Labs, Inc.


  • Ticker STTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,382,000
  • Market Cap $161M
  • Description
  • Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...
More about STTK
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.